According to the latest report by IMARC Group, titled, “Ablation Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, Offers a comprehensive analysis of the industry, which comprises insights on the ablation devices market share. The global ablation devices market size reached US$ 5.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.2 Billion by 2028, exhibiting a growth rate (CAGR) of 11.5% during 2023-2028.

Ablation devices are medical instruments that are used in minimally invasive (MI) procedures to eliminate or excise abnormal body tissues for therapeutic purposes. They rely on an electrosurgical generator connected to bipolar electrode arrays to deliver thermal energy to tissues. They assist in producing heat by radio frequency, energy, or a laser to cause small burns. They also aid in treating several diseases, such as ophthalmic, urologic, cardiovascular, and gynecological. They are used to treat lesions that generate scar tissues and block electrical signals initiating the arrhythmia. They are also utilized in the surgical treatment of numerous chronic diseases and to eradicate cancerous tumors and kidney stones. As these devices offer various advantages, such as quicker recovery, shorter stay in the hospital, and minimal risk of infections, they find extensive applications in hospitals, ambulatory surgical centers, and clinics across the globe.

Get a PDF Sample for more detailed market insights:

Ablation Devices Market Trends and Drivers:

At present, the growing demand for minimally invasive (MI) procedures due to several benefits, such as lesser pain, lower operative complications, rapid recovery, and smaller cosmetic incisions, represents one of the key factors driving the market. Besides this, the rising prevalence of chronic pains, such as headaches, low back, cancer, arthritis, neurogenic, and musculoskeletal, is propelling the growth of the market around the world. In addition, governments of several countries are organizing campaigns to raise awareness among the masses about the benefits of using ablation devices, which is strengthening the growth of the market. Apart from this, there is a rise in the demand for radiofrequency (RF) ablation devices during cancer treatment across the globe. This, along with various benefits offered by radiofrequency (RF) ablation devices, such as lower side effects, lesser recovery time, and can be used on patients suffering from multiple tumors, which is bolstering the growth of the market. Moreover, there is an increase in the integration of the latest technologies in ablation devices, such as multi-needle electrodes showcasing accuracy and portability, to offer enhanced patient safety and procedural efficiency around the world. This, coupled with the growing adoption of robotic technologies, is offering a positive market outlook. Additionally, key players operating in the industry are investing in research and development (R&D) activities to introduce the DIRECTSENSE technology that provides data for measuring the ability of the tissue to respond to radiofrequency energy before physicians deliver therapy. In line with this, the increasing geriatric population, is expected to positively influencing the market worldwide.

Ablation Devices Market 2023-2028 Competitive Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

  • Abbott Laboratories
  • Angio Dynamics Inc.
  • AtriCure Inc.
  • Boston Scientific Corporation
  • CONMED Corporation
  • Elekta AB (publ)
  • Johnson & Johnson
  • Medtronic plc
  • Olympus Corporation
  • Smith & Nephew plc.

The report has segmented the market based on device technology, application and end user.

Breakup by Device Technology:

  • Radiofrequency Devices
  • Laser/Light Ablation
  • Ultrasound Devices
  • Cryoablation Devices
  • Others

Breakup by Application:

  • Cancer Treatment
  • Cardiovascular Disease Treatment
  • Ophthalmologic Treatment
  • Gynecological Treatment
  • Urological Treatment
  • Cosmetic Surgery
  • Others

Breakup by End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Breakup by Region:

  • North America
  • Asia-Pacific
  • Europe
  • Latin America
  • Middle East and Africa

Ask Analyst for 10% Free Customized Report:

Key highlights of the report:

  • Market Performance (2017-2022)
  • Market Outlook (2023-2028)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact us:

USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Follow us on Twitter: @imarcglobal

Comments (0)
No login
Login or register to post your comment